# Pasithea Therapeutics Corp.: Form SCHEDULE 13D/A, filed Mar 6, 2025

- Company: [Pasithea Therapeutics Corp.](/companies/ktta.md) (CIK 1841330)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-06
- Accepted by EDGAR: Mar 6, 2025, 21:55 ET
- Period: not reported
- Accession: 0001013762-25-000233
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1841330/000101376225000233/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841330/000101376225000233/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841330/000101376225000233/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001013762-25-000233. Last ingested by Listed: Nov 6, 2026, 16:36 ET. No prices; not investment advice.